In recent weeks I've been trying to highlight some of the great contributions that our readers make to the Gumshoe universe, so today I'll again highlight a nice quick comment from reader "Steve", who posted a solid response to our Stansberry Alpha piece about his experience in selling puts. Real-world reminders that even really cool-seeming and safe-feeling investment ideas carry a risk that is always worth calculating and double-checking. You can see that comment here, or the full article here if you missed it the first time around. And In fact, the first article we posted this week was on a similar option-trading topic, about collecting a year's worth of dividends in one month -- you can see that one here.
What else graced the halls of Castle Gumshoe this week? Just read on ...
-------advertisement--------
How YOU could make $2,260/month Passive Income in 10 Minutes This is the #1 passive income strategy for traders and has a 100% success rate so far! Most people have only one income source. Let us show you how you can add a secondary passive income stream of $2,260/month, using a strategy that has returned 100% winners to date. Click Here to Get Started on YOUR $2,260/month Passive Income Stream -----------------------------------
Time for a look at a newsletter I've never written about before, Forbes Investor -- they're teasing a company that they think is on the verge of a turnaround and comeback that will rank with past huge successes like IBM, Hyundai or, well, Apple. So what is this company whose visionary CEO made a huge (and so far successful) decision a few years ago to transform their business? Click here and we'll tell you who Forbes Investor is pitching. And yes, this time it's a stock I own.
Michael Robinson is pitching a MEMS stock as a play on the increasing use of tiny chip sensors in medicine (like the $50 device that he thinks can end all disease -- that's more apocryphal) and other industries (already big in cell phones, in use in smart cities, in use for oil and gas exploration and seismic tracking , etc). So what's the company that he's pitching as a millionaire-maker? Click here for our examination and we'll tell you. And this week we also posted a new piece from "Doc Gumshoe," our favorite medical writer -- he raised some hackles with this one, about resveratrol and a number of other hot medical topics, but, of course, if you don't raise a few hackles when talking about health, supplements and the French Paradox, well, you're probably not saying anything very interesting. Here's his piece. He's taking on Alzheimer's next, so look out! Finally, we posted Myron Martin's latest piece about some micro caps and mining names for the Irregulars on Friday, and I shared some quick updates for the Irregulars on my portfolio and on some of our favorite past picks in a number of shorter pieces -- you can see all of those here. |
---------------------------------------------------
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice. You should speak with your financial advisor and understand everything fully before committing money to any investment. Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.
If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership. |
No comments:
Post a Comment